Aditxt (ADTX) Competitors $0.13 -0.01 (-4.43%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$0.13 0.00 (-3.42%) As of 08:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ADTX vs. EGRX, AIMD, OBSV, SNGX, ORGS, ADXN, NLSP, VRAX, RDHL, and APMShould you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include Eagle Pharmaceuticals (EGRX), Ainos (AIMD), ObsEva (OBSV), Soligenix (SNGX), Orgenesis (ORGS), Addex Therapeutics (ADXN), NLS Pharmaceutics (NLSP), Virax Biolabs Group (VRAX), RedHill Biopharma (RDHL), and Aptorum Group (APM). These companies are all part of the "pharmaceutical products" industry. Aditxt vs. Eagle Pharmaceuticals Ainos ObsEva Soligenix Orgenesis Addex Therapeutics NLS Pharmaceutics Virax Biolabs Group RedHill Biopharma Aptorum Group Aditxt (NASDAQ:ADTX) and Eagle Pharmaceuticals (NASDAQ:EGRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, community ranking, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership. Do insiders & institutionals hold more shares of ADTX or EGRX? 15.5% of Aditxt shares are held by institutional investors. Comparatively, 85.4% of Eagle Pharmaceuticals shares are held by institutional investors. 1.7% of Aditxt shares are held by company insiders. Comparatively, 28.9% of Eagle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is ADTX or EGRX more profitable? Eagle Pharmaceuticals' return on equity of 0.00% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets AditxtN/A -439.07% -122.96% Eagle Pharmaceuticals N/A N/A N/A Which has stronger valuation & earnings, ADTX or EGRX? Eagle Pharmaceuticals has higher revenue and earnings than Aditxt. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAditxt$640K2.92-$32.38MN/AN/AEagle Pharmaceuticals$316.61M0.03$35.64MN/AN/A Does the media prefer ADTX or EGRX? In the previous week, Aditxt and Aditxt both had 1 articles in the media. Eagle Pharmaceuticals' average media sentiment score of 0.00 beat Aditxt's score of -0.45 indicating that Eagle Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aditxt 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Eagle Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in ADTX or EGRX? Eagle Pharmaceuticals received 408 more outperform votes than Aditxt when rated by MarketBeat users. Likewise, 67.10% of users gave Eagle Pharmaceuticals an outperform vote while only 44.44% of users gave Aditxt an outperform vote. CompanyUnderperformOutperformAditxtOutperform Votes444.44% Underperform Votes555.56% Eagle PharmaceuticalsOutperform Votes41267.10% Underperform Votes20232.90% Which has more risk and volatility, ADTX or EGRX? Aditxt has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Eagle Pharmaceuticals has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. SummaryEagle Pharmaceuticals beats Aditxt on 9 of the 11 factors compared between the two stocks. Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADTX vs. The Competition Export to ExcelMetricAditxtPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.87M$6.52B$5.34B$9.11BDividend YieldN/A2.95%5.37%4.00%P/E RatioN/A4.2756.8413.06Price / Sales2.92310.261,275.3476.04Price / CashN/A22.6336.6132.89Price / Book0.004.964.874.58Net Income-$32.38M$154.90M$118.05M$224.84M7 Day Performance-2.66%1.35%1.47%2.37%1 Month Performance-29.34%0.41%2.54%4.40%1 Year Performance-99.92%3.08%25.37%20.10% Aditxt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADTXAditxt0.1718 of 5 stars$0.13-4.4%N/A-99.9%$1.87M$640,000.000.0060Gap UpEGRXEagle PharmaceuticalsN/A$0.65+16.1%N/A-85.5%$8.44M$257.55M0.00100AIMDAinos1.3279 of 5 stars$0.58-18.5%N/A-46.5%$8.16M$40,633.000.0040Gap DownOBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150Analyst ForecastSNGXSoligenix1.4612 of 5 stars$3.13-2.2%N/A-74.4%$7.86M$840,000.00-0.4220Positive NewsORGSOrgenesisN/A$1.62-10.0%N/AN/A$7.77M$662,000.000.00150ADXNAddex Therapeutics2.6571 of 5 stars$7.32-2.7%$30.00+310.1%+13.5%$7.75M$556,045.00-21.5130Gap UpNLSPNLS PharmaceuticsN/A$2.03-12.5%N/A+297.9%$7.74MN/A0.006Gap DownVRAXVirax Biolabs Group0.2519 of 5 stars$2.38-1.7%N/A+107.6%$7.70M$84,872.000.005Gap UpRDHLRedHill Biopharma0.1987 of 5 stars$5.79-1.2%N/A-99.0%$7.42M$3.71M-0.58210News CoveragePositive NewsAPMAptorum Group0.8877 of 5 stars$1.34-3.6%N/A-32.4%$7.02M$431,378.000.0030Positive NewsGap Up Related Companies and Tools Related Companies Eagle Pharmaceuticals Alternatives Ainos Alternatives ObsEva Alternatives Soligenix Alternatives Orgenesis Alternatives Addex Therapeutics Alternatives NLS Pharmaceutics Alternatives Virax Biolabs Group Alternatives RedHill Biopharma Alternatives Aptorum Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADTX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADTX Stock Alerts